drug · gene
patient view →CTx-001
Phase 2updated 2mo agoby Complement Therapeutics Ltd🔗 ChEMBL
Phase 2community read0 votes
Gene drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 1 investigational indication.
indications
indications
AMD
targets
B-cell lymphoma/leukemia 11A
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that